KADANT INC
For the period ended Dec 28, 2024. Filed Feb 25, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 25, 2025
Contents
Note
- Income Taxes
The components of income before provision for income taxes are as follows:
| (In thousands) | December 28, 2024 | December 30, 2023 | December 31, 2022 |
|---|---|---|---|
| Domestic | $51,417 | $57,810 | $46,558 |
| Foreign | 101,653 | 101,206 | 119,078 |
| $153,070 | $159,016 | $165,636 |
The components of the provision for income taxes are as follows:
| (In thousands) | December 28, 2024 | December 30, 2023 | December 31, 2022 |
|---|---|---|---|
| Current Provision: | |||
| Federal | $7,051 | $12,402 | $8,738 |
| Foreign | 29,414 | 28,587 | 26,032 |
| State | 2,819 | 3,170 | 1,977 |
| 39,284 | 44,159 | 36,747 | |
| Deferred Provision (Benefit): | |||
| Federal | 2,094 | 48 | 1,970 |
| Foreign | (1,222) | (2,594) | 4,233 |
| State | 360 | 597 | 956 |
| 1,232 | (1,949) | 7,159 | |
| $40,516 | $42,210 | $43,906 | |
The Company receives a tax deduction upon the vesting of RSUs. The Company recognizes excess income tax benefits and tax deficiencies related to stock-based compensation arrangements as discrete items within the provision for income taxes in the reporting period in which they occur. The Company recognized an income tax benefit of $523,000 in 2024, $354,000 in 2023 and $501,000 in 2022 in the accompanying consolidated statement of income.
| Table of Contents | |
|---|---|
| Kadant Inc. | 2024 Financial Statements |
The provision for income taxes in the accompanying consolidated statement of income differs from the provision calculated by applying the statutory federal income tax rate of 21% to income before provision for income taxes due to the following:
| (In thousands) | December 28, 2024 | December 30, 2023 | December 31, 2022 |
|---|---|---|---|
| Provision for Income Taxes at Statutory Rate | $32,145 | $33,393 | $34,784 |
| Increases (Decreases) Resulting From: | |||
| Foreign tax rate differential | 7,697 | 5,070 | 5,770 |
| State income taxes, net of federal income tax | 2,512 | 2,965 | 2,316 |
| Nondeductible expenses | 1,731 | 1,730 | 2,683 |
| U.S. tax (benefit) cost of foreign earnings | (1,379) | 1,270 | 932 |
| (Reversal of) provision for tax benefit reserves, net | (65) | 386 | (1,368) |
| Research and development tax credits | (503) | (520) | (425) |
| Excess tax benefit related to stock-based compensation | (401) | (276) | (377) |
| Change in valuation allowance | (203) | (684) | 318 |
| Other | (1,018) | (1,124) | (727) |
| $40,516 | $42,210 | $43,906 | |
The Company's net deferred tax liability consists of the following:
| (In thousands) | December 28, 2024 | December 30, 2023 |
|---|---|---|
| Deferred Tax Asset: | ||
| Net operating loss carryforwards | $9,623 | $11,300 |
| Lease liabilities | 9,094 | 6,820 |
| Inventory basis difference | 5,589 | 5,417 |
| Employee compensation | 5,196 | 4,690 |
| Capitalized research expenses | 4,682 | 4,159 |
| Reserves and accruals | 3,125 | 2,581 |
| Allowance for credit losses | 822 | 776 |
| Foreign, state, and alternative minimum tax credit carryforwards | 344 | 490 |
| Other | 153 | 214 |
| Deferred tax asset, gross | 38,628 | 36,447 |
| Less: valuation allowance | (7,570) | (7,829) |
| Deferred tax asset, net | 31,058 | 28,618 |
| Deferred Tax Liability: | ||
| Goodwill and intangible assets | (44,027) | (41,116) |
| Fixed asset basis difference | (13,372) | (11,764) |
| ROU assets | (8,754) | (5,969) |
| Provision for unremitted foreign earnings | (1,135) | (1,153) |
| Other | (2,919) | (2,361) |
| Deferred tax liability | (70,207) | (62,363) |
| Net deferred tax liability | $(39,149) | $(33,745) |
Deferred tax assets and liabilities are presented in the accompanying consolidated balance sheet within other assets and long-term deferred income taxes on a net basis by tax jurisdiction. The Company has established valuation allowances related to certain domestic and foreign deferred tax assets on deductible temporary differences, tax losses, and tax credit carryforwards. The valuation allowance at year-end 2024 was $7,570,000, consisting of $63,000 in the United States and $7,507,000 in foreign jurisdictions. The decrease in the valuation allowance in 2024 of $259,000 is related primarily to utilization of net operating losses and fluctuations in foreign currency exchange rates, partially offset by the valuation allowance recorded in purchase accounting. Compliance with ASC 740 requires the Company to periodically evaluate the necessity of establishing or adjusting a valuation allowance for deferred tax assets depending on whether it is more likely than not that a related tax benefit will be realized in future periods. When assessing the need for a valuation
| Table of Contents | |
|---|---|
| Kadant Inc. | 2024 Financial Statements |
allowance in a tax jurisdiction, the Company evaluates the weight of all available evidence to determine whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. As part of this evaluation, the Company considers its cumulative three-year history of earnings before income taxes, taxable income in prior carryback years, future reversals of existing taxable temporary differences, prudent and feasible tax planning strategies, and expected future results of operations. As of year-end 2024, the Company maintained a valuation allowance in the United States against a portion of its state net operating loss carryforwards in the United States and a valuation allowance in certain foreign jurisdictions due to the uncertainty of future profitability in the state and those foreign jurisdictions.
At year-end 2024, the Company had state net operating loss carryforwards of $9,146,000 and foreign net operating loss carryforwards of $40,136,000. The U.S. state net operating loss carryforwards begin to expire in 2025 and a portion does not expire. Of the foreign net operating loss carryforwards, $1,244,000 will expire in the years 2025 through 2044, and the remainder do not expire. As of year-end 2024, the Company had foreign tax credits carryforwards of $240,000. The foreign tax credit carryforward begins to expire in 2028. The utilization of this tax attribute is limited to the Company's future taxable income.
At year-end 2024, the Company had approximately $296,095,000 of unremitted foreign earnings. During 2024, the Company repatriated $27,658,000 of previously taxed foreign earnings to the United States and recognized a foreign exchange loss of $1,746,000 associated with these earnings. The Company intends to repatriate the distributable reserves of select foreign subsidiaries back to the United States and has recognized $584,000 of tax expense on the estimated repatriation amount during 2024. Except for these select foreign subsidiaries, the Company intends to indefinitely reinvest $255,324,000 of earnings of its foreign subsidiaries in order to support the current and future capital needs of their operations, including the repayment of the Company’s foreign debt. The related foreign withholding taxes, which would be required if the Company were to remit these foreign earnings to the United States, would be approximately $5,311,000.
The Company operates within multiple tax jurisdictions and could be subject to audit in those jurisdictions. Such audits can involve complex income tax issues, which may require an extended period of time to resolve and may cover multiple years. In management's opinion, adequate provisions for income taxes have been made for all years subject to audit.
As of year-end 2024, the Company had a liability of $14,510,000 for unrecognized tax benefits of which $6,032,000, if recognized, would reduce the effective tax rate. A reconciliation of unrecognized tax benefits is as follows:
| (In thousands) | December 28, 2024 | December 30, 2023 |
|---|---|---|
| Unrecognized Tax Benefits, Beginning of Year | $11,212 | $10,354 |
| Gross Increases – Tax Positions in Prior Periods | 80 | 44 |
| Gross Increases – Tax Positions in Prior Periods Arising from Acquisitions (a) | 4,372 | — |
| Gross Decreases – Tax Positions in Prior Periods | (25) | (37) |
| Gross Increases – Current-Period Tax Positions | 931 | 1,589 |
| Settlements | (85) | (130) |
| Lapses of Statutes of Limitations | (1,624) | (749) |
| Currency Translation | (351) | 141 |
| Unrecognized Tax Benefits, End of Year | $14,510 | $11,212 |
(a) Indemnification assets of $4,372,000 were also recorded.
A portion of the unrecognized tax benefits generated in 2024 is offset by deferred tax assets in the accompanying consolidated balance sheet. The Company recognizes accrued interest and penalties related to unrecognized tax benefits in the provision for income taxes. The Company has accrued $3,488,000 at year-end 2024 and $2,017,000 at year-end 2023 for the potential payment of interest and penalties. The interest and penalties included in the accompanying consolidated statement of income was an expense of $131,000 in 2024 and $120,000 in 2023.
The Company is currently under audit in certain of its foreign tax jurisdictions. It is reasonably possible that over the next fiscal year the amount of liability for unrecognized tax benefits may be reduced by up to $1,135,000 primarily from the expiration of tax statutes of limitations.
The Company remains subject to U.S. federal income tax examinations for the tax years 2019 through 2024, and to non-U.S. income tax examinations for the tax years 2015 through 2024. In addition, the Company remains subject to state and local income tax examinations in the United States for the tax years 2003 through 2024.
| Table of Contents | |
|---|---|
| Kadant Inc. | 2024 Financial Statements |
- Long-Term Obligations
Long-term obligations are as follows:
| (In thousands) | December 28, 2024 | December 30, 2023 |
|---|---|---|
| Revolving Credit Facility, due 2027 | $278,384 | $98,761 |
| Senior Promissory Notes, due 2025 to 2028 | 6,660 | 8,330 |
| Finance Leases, due 2025 to 2029 | 2,023 | 1,789 |
| Other Borrowings, due 2025 to 2028 | 1,460 | 1,995 |
| Total | 288,527 | 110,875 |
| Less: Current Maturities of Long-Term Obligations | (3,376) | (3,209) |
| Long-Term Obligations | $285,151 | $107,666 |
See Note 10, Fair Value Measurements and Fair Value of Financial Instruments, for the fair value information related to the Company's long-term obligations.
Revolving Credit Facility
On November 30, 2022, the Company entered into a sixth amendment to its unsecured multi-currency revolving credit facility, originally entered into on March 1, 2017 (as amended and restated to date, the Credit Agreement). Among other things, this amendment extended the maturity date to November 30, 2027, and increased the uncommitted, unsecured incremental borrowing facility from $150,000,000 to $200,000,000. Pursuant to the Credit Agreement, the Company has a borrowing capacity of $400,000,000 and interest on borrowings outstanding accrues and is payable in arrears calculated at one of the following rates selected by the Company:(i) the Base Rate, as defined, plus a margin of 0% to 1.25%, or (ii) Eurocurrency Rate, Term SOFR (plus a 10 basis point credit spread adjustment), Term CORRA, and RFR, as applicable and defined, plus a margin of 1.0% to 2.25%. The margin is determined based upon the ratio of the Company's total debt, net of unrestricted cash up to $50,000,000, to earnings before interest, taxes, depreciation, and amortization as defined in the Credit Agreement. Additionally, the Credit Agreement requires the payment of a commitment fee payable in arrears on the available borrowing capacity under the Credit Agreement, which ranges from 0.125% to 0.350%.
Obligations under the Credit Agreement may be accelerated upon the occurrence of an event of default, which includes customary events of default under such financing arrangements. In addition, the Credit Agreement contains negative covenants applicable to the Company and its subsidiaries, including financial covenants requiring the Company to maintain a maximum consolidated leverage ratio of 3.75 to 1.00, or, if the Company elects, for the quarter during which a material acquisition occurs and for the three fiscal quarters thereafter,4.25 to 1.00, and limitations on making certain restricted payments (including dividends and stock repurchases).
Loans under the Credit Agreement are guaranteed by certain domestic subsidiaries of the Company.
At year-end 2024, the outstanding balance under the Credit Agreement was $278,384,000, which included $71,384,000 of euro-denominated borrowings. The Company had $121,760,000 of borrowing capacity available at year-end 2024, which was calculated by translating its foreign-denominated borrowings using the administrative agent's borrowing date foreign exchange rates, in addition to the $200,000,000 uncommitted, unsecured incremental borrowing facility.
The weighted average interest rate for the outstanding balance under the Credit Agreement was 5.27% as of year-end 2024 and 5.24% as of year-end 2023.
Senior Promissory Notes
In 2018, the Company entered into an uncommitted, unsecured Multi-Currency Note Purchase and Private Shelf Agreement (Note Purchase Agreement). Simultaneously with the execution of the Note Purchase Agreement, the Company issued senior promissory notes (Initial Notes) in an aggregate principal amount of $10,000,000, with a per annum interest rate of 4.90% payable semiannually, and a maturity date of December 14, 2028. The Company was required to prepay a portion of the principal of the Initial Notes beginning on December 14, 2023 and for each year thereafter, and may optionally prepay the principal on the Initial Notes, together with any prepayment premium, at any time in accordance with the Note Purchase Agreement. The obligations of the Initial Notes may be accelerated upon an event of default as defined in the Note Purchase Agreement, which includes customary events of default under such financing arrangements.
The Initial Notes arepari passu with the Company’s indebtedness under the Credit Agreement, and any other senior debt, subject to certain specified exceptions, and participate in a sharing agreement with respect to the obligations of
| Table of Contents | |
|---|---|
| Kadant Inc. | 2024 Financial Statements |
the Company and its subsidiaries under the Credit Agreement. The Initial Notes are guaranteed by certain of the Company's domestic subsidiaries.
Debt Compliance
At year-end 2024, the Company was in compliance with the covenants related to its debt obligations.
Finance Leases
The Company's finance leases primarily relate to contracts for vehicles. See Note 9, Leases, for further information relating to the Company's finance leases.
Other Borrowings
At year-end 2024, other borrowings included $1,460,000 of debt obligations, which have maturity dates ranging from 2026 to 2028 and interest rates of up to 1.70%.
Annual Repayment Requirements
The following schedule presents the annual repayment requirements for the Company’s long-term obligations, excluding finance leases, as of year-end 2024.
| (In thousands) | Total |
|---|---|
| 2025 | $2,301 |
| 2026 | 2,093 |
| 2027 | 280,373 |
| 2028 | 1,737 |
| $286,504 |
- Commitments and Contingencies
Letters of Credit and Bank Guarantees
Outstanding letters of credit and bank guarantees issued on behalf of the Company, principally relating to performance obligations and customer deposit guarantees, totaled $13,872,000 at year-end 2024. Certain of the Company's contracts require the Company to provide a standby letter of credit or bank guarantee to a customer as beneficiary, limited in amount to a negotiated percentage of the total contract value, in order to guarantee warranty and performance obligations of the Company under the contract. Typically, these standby letters of credit and bank guarantees expire without being drawn by the beneficiary.
Right of Recourse
In the ordinary course of business, the Company's Chinese subsidiaries may receive banker's acceptance drafts from customers as payment for their trade accounts receivable. The drafts are non-interest-bearing obligations of the issuing bank and generally mature withinsix months of the origination date. The Company's Chinese subsidiaries may use these banker's acceptance drafts prior to the scheduled maturity date to settle outstanding accounts payable with vendors. Banker's acceptance drafts transferred to vendors are subject to customary right of recourse provisions prior to their scheduled maturity dates. The Company had $7,952,000 at year-end 2024 and $9,090,000 at year-end 2023 of banker's acceptance drafts subject to recourse, which were transferred to vendors and had not reached their scheduled maturity dates. Historically, the banker's acceptance drafts have settled upon maturity without any claim of recourse against the Company.
Contingencies
In the ordinary course of business, the Company is, at times, required to issue limited performance guarantees, some of which do not require the issuance of letters of credit to customers in support of these guarantees, relating to its equipment and systems. The Company generally limits its liability under these guarantees to amounts typically capped at 10% or less of the value of the contract. The Company believes that it has adequate reserves for any potential liability in connection with such guarantees.
| Table of Contents | |
|---|---|
| Kadant Inc. | 2024 Financial Statements |
Litigation
From time to time, the Company is subject to various claims and legal proceedings covering a range of matters that arise in the ordinary course of business. Such litigation may include, but is not limited to, claims and counterclaims by and against the Company for breach of contract or warranty, canceled contracts, product liability, or bankruptcy-related claims. For legal proceedings in which a loss is probable and estimable, the Company accrues a loss based on the low end of the range of estimated loss when there is no better estimate within the range. If the Company were found to be liable for any of the claims or counterclaims against it, the Company would incur a charge against earnings for amounts in excess of legal accruals.
- Gain on Sale and Other Costs, Net
The components of gain on sale and other costs, net are as follows:
| (In thousands) | December 28, 2024 | December 30, 2023 | December 31, 2022 |
|---|---|---|---|
| Gain on Sale of Assets | $— | $— | $(20,190) |
| Restructuring and Impairment Costs | — | 766 | 1,334 |
| Other Costs (Income) | 658 | (43) | — |
| $658 | $723 | $(18,856) |
Gain on Sale of Assets
The Company entered into several agreements with the local government in China to sell its then existing manufacturing building and land use rights at one of its subsidiaries in China for $25,159,000 and relocate to a new facility (China Transaction). The agreements became effective in the first quarter of 2022 after a 31% down payment was received, including 25% in 2021 and 6% in the first quarter of 2022, and a land use right in a new location was secured. As a result, the Company recognized a gain on the China Transaction of $20,190,000, or $15,143,000, net of deferred taxes of $5,047,000, in the first quarter of 2022. A receivable of $16,082,000 was recognized for the present value of the remaining amount of the sale proceeds, which was due the earlier of when the government sells the property or withintwo years from the effective date of the agreements. The government settled $685,000 of the receivable in 2024. The outstanding receivable was $14,377,000 at year-end 2024, which the Company expects will be repaid in full, although the timing is uncertain. The subsidiary, which is part of the Industrial Processing segment, relocated to its new facility during the third quarter of 2023.
A summary of the change in the outstanding receivable on the China Transaction, which is included in other current assets in the consolidated balance sheet, is as follows:
| (In thousands) | Total |
|---|---|
| Balance at December 30, 2023 | $15,410 |
| Accretion of interest income | 135 |
| Proceeds received | (685) |
| Currency translation | (483) |
| Balance at December 28, 2024 | $14,377 |
Other Costs, Net
Restructuring and Impairment Costs
The Company's restructuring plans within its Flow Control Segment are as follows:
2023 Restructuring Plans
The Company incurred restructuring and impairment costs of $400,000 in 2023 related to the consolidation of a small manufacturing operation into a larger facility in Germany. These charges consisted of severance costs of $335,000 for the termination of 10 employees, facility and other closure costs of $29,000, and asset-write downs of $36,000.
The Company incurred restructuring costs of $366,000 in 2023 related to the termination of a contract at one of its operations in Germany.
| Table of Contents | |
|---|---|
| Kadant Inc. | 2024 Financial Statements |
2021 Restructuring Plan
The Company incurred restructuring costs of $568,000 in 2022 related to its plan to eliminate a redundant ceramic blade manufacturing operation in France. These charges consisted of severance costs for the termination offive employees and facility and other closure costs.
The Company incurred restructuring costs of $35,000 and impairment costs of $731,000 within its Industrial Processing segment during 2022. The impairment costs included $549,000 primarily related to the write-down of inventory from the Company's operations in Russia and $182,000 related to the write-down of certain fixed assets that were not moved to the new manufacturing facility in China as part of the China Transaction.
A summary of the changes in accrued restructuring costs included in other current liabilities in the accompanying consolidated balance sheet are as follows:
| (In thousands) | Severance Costs | Contract Termination Costs | Facility and Other Closure Costs | Total |
|---|---|---|---|---|
| 2023 Restructuring Plans | ||||
| Provision | $335 | $366 | $29 | $730 |
| Usage | (138) | (63) | (29) | (230) |
| Currency translation | 4 | 10 | — | 14 |
| Balance at December 30, 2023 | $201 | $313 | $— | $514 |
| Usage | (195) | (303) | — | (498) |
| Currency translation | (6) | (10) | — | (16) |
| Balance at December 28, 2024 | $— | $— | $— | $— |
| 2021 Restructuring Plan | ||||
| Balance at January 1, 2022 | $156 | $— | $— | $156 |
| Provision | 205 | — | 398 | 603 |
| Usage | (159) | — | (231) | (390) |
| Currency translation | (13) | — | 33 | 20 |
| Balance at December 31, 2022 | $189 | $— | $200 | $389 |
| Usage | (187) | — | (199) | (386) |
| Currency translation | (2) | — | (1) | (3) |
| Balance at December 30, 2023 | $— | $— | $— | $— |
Other Costs (Income)
In 2024, the Company recognized a loss of $658,000 from the recognition of a currency translation adjustment associated with the liquidation of a small foreign subsidiary in the Flow Control segment.
In 2023, in connection with the China Transaction, the Company recognized income of $841,000 related to the outsourcing of demolition and cleanup of the then existing manufacturing building in China and sale of the remaining fixed assets. In addition, the Company incurred relocation costs of $798,000 in 2023 related to the relocation of machinery and equipment and administrative offices to the new manufacturing facility.
- Leases
The Company enters into operating and finance lease commitments primarily for its manufacturing and office space, vehicles, and equipment that expire on various dates over the next 17 years, some of which include assumed options to extend the lease term for up to 10 years. In addition, the Company leases land associated with certain of its buildings in Canada and China under long-term leases expiring in 2032 to 2071. The lease in Canada also includes an assumed option to extend the term for up to 10 years.
The components of lease expense are as follows:
| (In thousands) | December 28, 2024 | December 30, 2023 | December 31, 2022 |
|---|---|---|---|
| Operating Lease Cost (a) | $8,153 | $6,355 | $5,870 |
| Short-Term Lease Cost | 810 | 698 | 697 |
| Table of Contents | |
|---|---|
| Kadant Inc. | 2024 Financial Statements |
| (In thousands) | December 28, 2024 | December 30, 2023 | December 31, 2022 |
|---|---|---|---|
| Finance Lease Cost: | |||
| ROU asset amortization | $1,168 | $1,103 | $1,026 |
| Interest on lease liabilities | 100 | 74 | 52 |
| Total Finance Lease Cost | 1,268 | 1,177 | 1,078 |
| Total Lease Costs | $10,231 | $8,230 | $7,645 |
(a) Includes variable lease costs of $747,000 in 2024, $961,000 in 2023, and $478,000 in 2022.
Supplemental cash flow information related to leases is as follows:
| (In thousands) | December 28, 2024 | December 30, 2023 | December 31, 2022 |
|---|---|---|---|
| Cash Paid for Amounts Included in the Measurement of Lease Liabilities: | |||
| Operating cash flows from operating leases | $8,282 | $6,475 | $6,159 |
| Operating cash flows from finance leases | $100 | $74 | $51 |
| Financing cash flows from finance leases | $1,169 | $1,100 | $1,002 |
| ROU Assets Obtained in Exchange for Lease Obligations: | |||
| Operating leases (a) | $17,496 | $8,120 | $4,002 |
| Finance leases | $1,598 | $989 | $1,468 |
(a) Includes ROU assets of $10,847,000 in 2024 obtained in connection with the Company's acquisitions.
Supplemental balance sheet information related to leases is as follows:
| (In thousands) · Balance Sheet Line Item · December 28, 2024 · December 30, 2023 | ||||
|---|---|---|---|---|
| Operating Leases: | ||||
| ROU assets | Other assets | $36,484 | $25,129 | |
| Total operating lease assets | $36,484 | $25,129 | ||
| Short-term liabilities | Other current liabilities | $6,548 | $5,389 | |
| Long-term liabilities | Other long-term liabilities | 27,768 | 19,350 | |
| Total operating lease liabilities | $34,316 | $24,739 | ||
| Finance Leases: | ||||
| ROU assets, at cost | Property, plant, and equipment, at cost | $4,077 | $4,037 | |
| ROU assets accumulated amortization | Accumulated depreciation and amortization | (2,094) | (2,288) | |
| ROU assets, net | Property, plant, and equipment, net | $1,983 | $1,749 | |
| Short-term obligations | Current maturities of long-term obligations | $1,075 | $983 | |
| Long-term obligations | Long-term obligations | 948 | 806 | |
| Total finance lease liabilities | $2,023 | $1,789 | ||
| December 28, 2024 | December 30, 2023 | |
|---|---|---|
| Weighted Average Remaining Lease Term (in years): | ||
| Operating leases | 8.0 | 6.8 |
| Finance leases | 2.1 | 2.0 |
| Weighted Average Discount Rate: | ||
| Operating leases | 4.52% | 4.08% |
| Finance leases | 5.11% | 4.71% |
| Table of Contents | |
|---|---|
| Kadant Inc. | 2024 Financial Statements |
As of December 28, 2024, future lease payments for lease liabilities are as follows:
| Operating · Finance | ||
|---|---|---|
| (In thousands) | Leases | Leases |
| 2025 | $7,824 | $1,148 |
| 2026 | 6,775 | 752 |
| 2027 | 5,527 | 202 |
| 2028 | 3,842 | 24 |
| 2029 | 2,831 | 2 |
| 2030 and Thereafter | 14,637 | — |
| Total Future Lease Payments | 41,436 | 2,128 |
| Less: Imputed Interest | (7,120) | (105) |
| Present Value of Lease Payments | $34,316 | $2,023 |
As of December 28, 2024, the Company had no significant operating and finance leases that had not yet commenced.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.